This page was checked in October 2026. FDA rules and fees change, so confirm them before you act. We are not lawyers or FDA consultants.
FDA registration for pharmaceuticals: the short answer
| Question | Answer |
|---|---|
| Does a Pakistani drug plant need FDA registration? | Yes. Every plant that makes, packs or labels drugs for the US must register and list each drug. |
| When must a drug plant register with the FDA? | Before the first shipment. Then every year between October 1 and December 31. |
| Does a foreign drug plant need a US agent? | Yes. Every foreign drug plant must name a US agent. |
| Do medicines made in Pakistan need FDA approval? | Yes, most do. Prescription drugs need FDA approval. Some over-the-counter medicines do not, if they follow the FDA monograph for that product type. |
| Is there an FDA fee for drug plant registration? | No fee to register. But a foreign plant making finished generic drugs pays $245,033 a year, and an over-the-counter monograph drug plant pays $47,891 a year (October 2026 to September 2027). |
Getting your medicines ready for the US market
Our part in the process:
- Data Universal Numbering System (DUNS) number, labeler code and plant registration, filed by our partners
- Listing every drug you make for the US, with updates each June and December
- A partner review of which medicines need FDA approval
- Outreach to US brands that want a contract plant to make their drugs, through our US Sales Desk
- Partner costs quoted before the work begins
- We never sign a deal on your behalf
- All our service prices are public
If your plant makes medicines or active ingredients for export, contact us now to plan your US registration.
How do you register a drug plant with the FDA?
A foreign drug plant registers with the FDA electronically, gets a labeler code, lists every drug and renews every year.
- Get a free DUNS number for the plant. It is an ID number the FDA uses to identify the site.
- Get a labeler code from the FDA. It is the first part of each drug's National Drug Code (NDC).
- Register the plant electronically with the FDA. Name your US agent and the US importers you know of.
- List every drug you make for the US.
- Renew every year between October 1 and December 31 (21 CFR 207.29). Update your drug listings every June and December (21 CFR 207.57).
The FDA only accepts these filings in its own electronic format, so most foreign plants hire a US regulatory firm. See our FDA registration renewal guide for the yearly steps.
Does your drug need FDA approval?
Most prescription drugs need FDA approval before sale, while many over-the-counter medicines can be sold without approval if they follow an FDA monograph exactly. An FDA monograph is a rule book for a type of over-the-counter medicine: which ingredients, what strength and what the label must say.
| Type of drug | What it needs |
|---|---|
| New prescription drug | An approved New Drug Application (NDA) |
| Generic drug | An approved generic drug application (ANDA). A foreign plant that makes the finished drug pays $245,033 a year (FY2027) |
| Over-the-counter drug that follows an FDA monograph, such as many pain relievers and antacids | No approval before sale, but it must follow the monograph exactly. Plants pay $47,891 a year (FY2027) |
| Active pharmaceutical ingredients (API) | Registration and listing. A foreign API plant named in a generic drug application pays $54,680 a year (FY2027) |
FDA fiscal year 2027 (FY2027) runs from October 1, 2026 to September 30, 2027. The fees are set in the Federal Register notices for generic drug fees under the Generic Drug User Fee Amendments (GDUFA) and over-the-counter monograph drug fees under the Over-the-Counter Monograph Drug User Fee Program (OMUFA), both published July 30, 2026.
Which quality rules and inspections apply to drug plants?
Foreign drug plants must follow the FDA's current good manufacturing practice (CGMP) rules, and the FDA can inspect them.
- The FDA inspects foreign plants. A failed inspection can lead to a warning letter or an import alert, which stops your shipments at the US port.
- Keep complete, honest records. Missing, changed or false records are a common reason for FDA action against foreign plants.
- Pakistan is already named on FDA import alerts for drugs from plants that failed good manufacturing practice (Import Alert 66-40), and for unapproved drugs sold in the US (Import Alert 66-41).
Are herbal and Unani medicines drugs under US law?
Herbal and Unani remedies sold to treat or cure a disease are drugs under US law, so they cannot be sold without FDA approval. Some can be sold as supplements, with no disease claims. See FDA registration for herbal products and supplements.
Can a Pakistani plant start as a contract maker for a US company?
Yes. Many foreign drug makers start by making medicines for a US company that holds the FDA approval. That company files the application. Your plant still registers, lists the drugs and must pass inspection.
How we help
We are not an FDA consultant. For a drug plant, a US regulatory firm handles the filings from day one, and a US agent is named for the plant. Our role is to coordinate them and keep you informed.
Exploring the US market for your medicines?
If contract making is your way in, we can introduce your plant to US companies that hire overseas plants to make their medicines.
More FDA registration guides
FDA registrationHerbal products and supplements
FDA registrationCosmetics
FDA registrationFDA registration for Pakistani exporters
FDA registration for pharmaceuticals: questions exporters ask
Can a Pakistani pharmaceutical company sell in the US?
Yes, if the plant is registered, the drugs are listed and approved where needed, and the plant meets FDA quality rules.
Does FDA registration mean my drug is approved?
No. Registration and listing are separate from approval. Most prescription drugs need an approved application.
How often do drug makers register?
Every year, between October 1 and December 31.
Do I need a US agent for drug registration?
Yes. Every foreign drug plant must name a US agent.
